Trajectories of disease evolution upon treatment initiation in systemic lupus erythematosus: results from four clinical trials of belimumab

Systemic Lupus Erythematosus

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Rheumatology (Oxford)

Nakanishi E, Matsushita M, Minowa K, Tada K, Kawamoto T, Kusaoi M, Amano H, Kon T, Morimoto S, Ikeda K, Suzuki S, Nozawa K, Yang KS, Matsudaira R, Katagiri A, Tsushima H, Urasaki W, Nojiri S, Yamaji K, Tamura N

doi: 10.1093/rheumatology/keaf349

Systemic Lupus Erythematosus

Enhancing systemic lupus erythematosus treatment outcomes with an early initiation of belimumab: insights from a multicenter retrospective study within the first five years

Arthritis Res Ther

Kojima K, Ichinose K, Umeda M, Shimizu T, Sato S, Suzuki T, Nakashima Y, Okada A, Horai Y, Fujikawa K, Aramaki T, Miyashita T, Furuyama M, Matsuoka N, Kawakami A

doi: 10.1186/s13075-025-03581-0

Systemic Lupus Erythematosus

LLDAS and remission attainment with anifrolumab treatment in patients with systemic lupus erythematosus: results from the TULIP and long-term extension randomised controlled trials

Ann Rheum Dis

Morand EF, van Vollenhoven R, Furie RA, Kalunian KC, Manzi S, Abreu G, Tummala R, Duncan EA, Al-Mossawi H, Lindholm C

doi: 10.1016/j.ard.2025.01.016

Systemic Lupus Erythematosus

Clinical Presentation, Care Pathways, and Delays in Access to Specialized Care in Patients With Systemic Lupus Erythematosus: A Study From Lupus Midwest Network (LUMEN 💡)

Arthritis Care Res (Hoboken)

Sanchez-Rodriguez A, Meade-Aguilar JA, Yang JX, Figueroa-Parra G, Hanson AC, Langenfeld HE, Thanarajasingam U, Chamberlain AM, Greenlund KJ, Barbour KE, Crowson CS, Duarte-García A

doi: 10.1002/acr.25445

Systemic Lupus Erythematosus

Genetic variability associates with ancestry, age at disease onset, organ involvement and disease severity in juvenile-onset systemic lupus erythematosus

Clin Immunol

Natoli V, Charras A, Hasoon MSR, Jorgensen AL, Smith EMD, Gutiérrez EC, Beresford MW, Hedrich CM, UK JSLE Cohort Study Group

doi: 10.1016/j.clim.2025.110540

Systemic Lupus Erythematosus

Implementation outcomes of a patient decision-aid in a diverse population with systemic lupus erythematosus in 15 U.S. rheumatology clinics

Rheumatology (Oxford)

Singh JA, Hearld LR, Eisen S, Chatham WW, Narain S, Annapureddy N, Kamen DL, Trotter K, Majithia V, Lee Ching C, Aouhab Z, Venuturupalli S, Wallace DJ, Ramsey-Goldman R, Kim A, McMahon M, Sam Lim S, Bhairavarasu K, Meara A, Kalunian K, Beasley M, Implementing DEcision-Aid for Lupus in clinics (IDEAL) Consortium

doi: 10.1093/rheumatology/keaf205

Systemic Lupus Erythematosus

Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: A longitudinal cohort study

Semin Arthritis Rheum

Ibarguengoitia-Barrena O, Riancho-Zarrabeitia L, Plaza Z, Rúa-Figueroa Í, Roberts K, Martínez-Taboada V, Menor-Almagro R, Serrano-Benavente B, Rubio-Muñoz P, Galindo-Izquierdo M, Fernández-Nebro A, Ruiz-Lucea ME, Calvo-Alén J, Tomero-Muriel EG, Uriarte-Isacelaya E, Pecondon-Españo A, Freire M, García-Fernández J, Expósito L, Ibañez-Barceló M, Aurrecoechea E, Montilla C, Rosas-Gómez de Salazar J, García-Villanueva MJ, Caño-Alameda R, Toyos-Sáenz de Miera FJ, Nóvoa-Medina FJ, Moriano-Morales C, Bonilla G, Narváez FJ, Andréu JL, Arévalo-Salaet M, Horcada L, Cobo T, Lozano-Rivas N, Bohorquez C, Iñíguez-Ubiaga CL, Salgado-Perez E, Torrente-Segarra V, Salman Monte TC, Oller JE, Pego-Reigosa JM, RELESSER research group

doi: 10.1016/j.semarthrit.2025.152819

Systemic Lupus Erythematosus

Factors and outcomes related to clinical inertia in systemic lupus erythematosus: a multicentre LUNA cohort study

Rheumatology (Oxford)

Miyake H, Kida T, Yoshimi R, Michizu Y, Nishimura K, Sada KE, Miyawaki Y, Matsuo Y, Ohno S, Kajiyama H, Sato S, Shimojima Y, Fujiwara M, Takatani A, Onishi T, Katsushima M, Ida T, Umekita K, Nakano H, Ikeda K, Ichinose K, Onishi A

doi: 10.1093/rheumatology/keaf504

Systemic Lupus Erythematosus

Temporal trends in glucocorticoids and hydroxychloroquine for treatment of systemic lupus erythematosus in Sweden

Rheumatology (Oxford)

Dominicus A, Mageau A, Nguyen NV, Blomkvist Sporre K, Svenungsson E, Arkema EV

doi: 10.1093/rheumatology/keaf192

Related content

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Enhancing systemic lupus erythematosus treatment outcomes with an early initiation of belimumab: insights from a multicenter retrospective study within the first five years

LLDAS and remission attainment with anifrolumab treatment in patients with systemic lupus erythematosus: results from the TULIP and long-term extension randomised controlled trials

Clinical Presentation, Care Pathways, and Delays in Access to Specialized Care in Patients With Systemic Lupus Erythematosus: A Study From Lupus Midwest Network (LUMEN 💡)

Genetic variability associates with ancestry, age at disease onset, organ involvement and disease severity in juvenile-onset systemic lupus erythematosus

Implementation outcomes of a patient decision-aid in a diverse population with systemic lupus erythematosus in 15 U.S. rheumatology clinics

Serological clusters in systemic lupus erythematosus and its clinical and prognostic implications: A longitudinal cohort study

Factors and outcomes related to clinical inertia in systemic lupus erythematosus: a multicentre LUNA cohort study

Temporal trends in glucocorticoids and hydroxychloroquine for treatment of systemic lupus erythematosus in Sweden